Synapse - Works

Results (2639)

FDG-PET scans as a staging study for T-cell lymphomas: High rates of positivity do not result in frequent changes in stage

Meeting Abstract

Horwitz, S. M.; Foss, F.; Goldfarb, S.; Molina, A.; Hamlin, P. A.; O'Connor, O. A.; Cammarata, M.; Moskowitz, C. H.; Zelenetz, A. D.
Blood (2006)

Fulltext@MSK | Save

Relapsed and refractory primary mediastinal diffuse large B-cell lymphoma: Outcome with ICE-based treatment

Meeting Abstract

Hamlin, P. A.; Dickson, M.; Kewalramani, T.; Horwitz, S. M.; Portlock, C. S.; Yahalom, J.; Zelenetz, A. D.; Moskowitz, C. H.
Blood (2006)

Fulltext@MSK | Save

The schedule dependent combination of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) produces minimal toxicity, even at relatively high doses of proteasome inhibitor, in patients with relapsed/refractory indolent B-cell lymphomproliferative disorders

Meeting Abstract

Gerecitano, J.; Portlock, C.; Noy, A.; Hamlin, P.; Moskowitz, C.; Straus, D.; Horwitz, S. M.; Palomba, M. L.; Dumitrescu, O. L.; Pappanicholaou, J.; more...
Blood (2006)

Fulltext@MSK | Save

Feasibility of a self-administered geriatric assessment for cancer patients

Meeting Abstract

Gardes, J. H.; Zuckerman, E.; Lichtman, S. M.; Hamlin, P.; Kelly, E.; Lachs, M.; Hurria, A.
Journal of the American Geriatrics Society (2006)

Fulltext@MSK | Save

Initial therapeutic strategy in follicular lymphoma (FL): An analysis from the National LymphoCare Study (NLCS)

Meeting Abstract

Friedberg, J. W.; Huang, J.; Dillon, H.; Farber, C.; Feliciano, S.; Hainsworth, J.; Link, B.; Steis, R.; Vose, J.; Zelenetz, A.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Phase III trial of active immunotherapy (FavId (R), Id/KLH) following rituximab induction therapy: Clinical responses in patients (pts) with follicular non-Hodgkin's lymphoma (fNHL)